Treating to target patients with primary hyperlipidemia: Comparison of the effects of atorvastatin and rosuvastatin (the atoros study)

被引：0
|
作者：
Milionis, H.
Rizos, E.
Kostapanos, M.
Filippatos, T.
Goudevenos, J.
Mikhailidis, D.
Elisaf, M.
机构：
[1] Univ Ioannina, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Royal Free Hosp, Dept Clin Biochem, London NW3 2QG, England
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)82339-1
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
ThP16381
引用
收藏
页码：577 / 577
页数：1
相关论文
共 50 条
  • [21] Comparison of Effects of Rosuvastatin and Atorvastatin on Plaque Regression in Korean Patients With Untreated Intermediate Coronary Stenosis
    Hong, Young Joon
    Jeong, Myung Ho
    Hachinohe, Daisuke
    Ahmed, Khurshid
    Choi, Yun Ha
    Cho, Sook Hee
    Hwang, Seung Hwan
    Ko, Jum Suk
    Lee, Min Goo
    Park, Keun Ho
    Sim, Doo Sun
    Yoon, Nam Sik
    Yoon, Hyun Ju
    Kim, Kye Hun
    Park, Hyung Wook
    Kim, Ju Han
    Ahn, Youngkeun
    Cho, Jeong Gwan
    Park, Jong Chun
    Kang, Jung Chaee
    CIRCULATION JOURNAL, 2011, 75 (02) : 398 - 406
  • [22] Comparision of Effects of Rosuvastatin Versus Atorvastatin Treatment on Plasma Levels of Asymmetric Dimethylarginine in Patients With Hyperlipidemia Having Coronary Artery Disease
    Kurtoglu, Ertugrul
    Balta, Sevket
    Sincer, Isa
    Altas, Yakup
    Atas, Halil
    Yilmaz, Mucahid
    Korkmaz, Hasan
    Erdem, Kenan
    Akturk, Erdal
    Demirkol, Sait
    Can, Cagdas
    ANGIOLOGY, 2014, 65 (09) : 788 - 793
  • [23] An assessment of the efficacy of atorvastatin in treating patients with dyslipidaemia to target LDL-cholesterol goals: The atorvastatin matrix study
    McVey, D
    Patel, H
    Eminton, Z
    Maton, S
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (07) : 509 - 513
  • [24] MODELING THE CARDIOVASCULAR EFFECTS OF SWITCHING PATIENTS FROM ROSUVASTATIN TO ATORVASTATIN
    Folse, H.
    Schuetz, C. A.
    Rengarajan, B.
    Sternhufvud, C.
    Gandhi, S. K.
    VALUE IN HEALTH, 2013, 16 (07) : A513 - A513
  • [25] Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia
    Bays, Harold E.
    Averna, Maurizio
    Majul, Claudio
    Muller-Wieland, Dirk
    De Pellegrin, Annamaria
    Giezek, Hilde
    Lee, Raymond
    Lowe, Robert S.
    Brudi, Philippe
    Triscari, Joseph
    Farnier, Michel
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (12): : 1885 - 1895
  • [26] Effects of morning versus evening administration of atorvastatin in patients with hyperlipidemia
    Plakogiannis, R
    Cohen, H
    Taft, D
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (23) : 2491 - 2494
  • [27] Effects of low doses of atorvastatin in patients with familial combined hyperlipidemia
    Bottazzo, S
    Severi, G
    Fazzin, G
    ATHEROSCLEROSIS, 1998, 138 : S8 - S8
  • [28] Effects of rosuvastatin and atorvastatin on plasma lipids in Type 2 diabetes patients in the MERCURY I study
    Schuster, H
    Barter, PJ
    Stender, S
    Cheung, RC
    Bonnet, J
    Morrell, JM
    Watkins, C
    Kallend, D
    DIABETOLOGIA, 2004, 47 : A409 - A409
  • [29] Effects of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidemia (FCH)
    ter Avest, E
    Abbink, EJ
    de Graaf, J
    Tack, CJ
    Stalenhoef, AFH
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 123 - 123
  • [30] Effects of rosuvastatin on serum homocysteine, vitamin B12 and folic acid levels in patients with primary hyperlipidemia
    Chasiotis, G
    Milionis, H
    Gazi, I
    Filippatos, T
    Bairaktari, E
    Elisaf, M
    Seferiadis, K
    CLINICA CHIMICA ACTA, 2005, 355 : S306 - S306
12345